Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
Identifieur interne : 003861 ( Main/Exploration ); précédent : 003860; suivant : 003862Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
Auteurs : P. Seeman [Canada] ; R. Corbett ; H H Van TolSource :
- Advances in pharmacology (San Diego, Calif.) [ 1054-3589 ] ; 1998.
English descriptors
- KwdEn :
- Antipsychotic Agents (adverse effects), Clozapine (metabolism), Dopamine (metabolism), Dopamine D2 Receptor Antagonists, Humans, Muscarinic Antagonists, Parkinson Disease, Secondary (chemically induced), Parkinson Disease, Secondary (prevention & control), Radioligand Assay, Receptor, Serotonin, 5-HT2A, Receptors, Dopamine D2 (metabolism), Receptors, Dopamine D4, Receptors, Muscarinic (metabolism), Receptors, Serotonin (metabolism), Serotonin Antagonists.
- MESH :
- chemical , adverse effects : Antipsychotic Agents.
- chemical , metabolism : Clozapine, Dopamine, Receptors, Dopamine D2, Receptors, Muscarinic, Receptors, Serotonin.
- chemical : Dopamine D2 Receptor Antagonists, Muscarinic Antagonists, Receptor, Serotonin, 5-HT2A, Receptors, Dopamine D4, Serotonin Antagonists.
- chemically induced : Parkinson Disease, Secondary.
- prevention & control : Parkinson Disease, Secondary.
- Humans, Radioligand Assay.
PubMed: 9327943
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001786
- to stream PubMed, to step Curation: 001786
- to stream PubMed, to step Checkpoint: 001786
- to stream Ncbi, to step Merge: 002603
- to stream Ncbi, to step Curation: 002603
- to stream Ncbi, to step Checkpoint: 002603
- to stream Main, to step Merge: 003E72
- to stream Main, to step Curation: 003861
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.</title>
<author><name sortKey="Seeman, P" sort="Seeman, P" uniqKey="Seeman P" first="P" last="Seeman">P. Seeman</name>
<affiliation wicri:level="4"><nlm:affiliation>Pharmacology Department, University of Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Pharmacology Department, University of Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Corbett, R" sort="Corbett, R" uniqKey="Corbett R" first="R" last="Corbett">R. Corbett</name>
</author>
<author><name sortKey="Van Tol, H H" sort="Van Tol, H H" uniqKey="Van Tol H" first="H H" last="Van Tol">H H Van Tol</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1998">1998</date>
<idno type="RBID">pubmed:9327943</idno>
<idno type="pmid">9327943</idno>
<idno type="wicri:Area/PubMed/Corpus">001786</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001786</idno>
<idno type="wicri:Area/PubMed/Curation">001786</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001786</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001786</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001786</idno>
<idno type="wicri:Area/Ncbi/Merge">002603</idno>
<idno type="wicri:Area/Ncbi/Curation">002603</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002603</idno>
<idno type="wicri:doubleKey">1054-3589:1998:Seeman P:dopamine:d:receptors</idno>
<idno type="wicri:Area/Main/Merge">003E72</idno>
<idno type="wicri:Area/Main/Curation">003861</idno>
<idno type="wicri:Area/Main/Exploration">003861</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.</title>
<author><name sortKey="Seeman, P" sort="Seeman, P" uniqKey="Seeman P" first="P" last="Seeman">P. Seeman</name>
<affiliation wicri:level="4"><nlm:affiliation>Pharmacology Department, University of Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Pharmacology Department, University of Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Corbett, R" sort="Corbett, R" uniqKey="Corbett R" first="R" last="Corbett">R. Corbett</name>
</author>
<author><name sortKey="Van Tol, H H" sort="Van Tol, H H" uniqKey="Van Tol H" first="H H" last="Van Tol">H H Van Tol</name>
</author>
</analytic>
<series><title level="j">Advances in pharmacology (San Diego, Calif.)</title>
<idno type="ISSN">1054-3589</idno>
<imprint><date when="1998" type="published">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic Agents (adverse effects)</term>
<term>Clozapine (metabolism)</term>
<term>Dopamine (metabolism)</term>
<term>Dopamine D2 Receptor Antagonists</term>
<term>Humans</term>
<term>Muscarinic Antagonists</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Parkinson Disease, Secondary (prevention & control)</term>
<term>Radioligand Assay</term>
<term>Receptor, Serotonin, 5-HT2A</term>
<term>Receptors, Dopamine D2 (metabolism)</term>
<term>Receptors, Dopamine D4</term>
<term>Receptors, Muscarinic (metabolism)</term>
<term>Receptors, Serotonin (metabolism)</term>
<term>Serotonin Antagonists</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Clozapine</term>
<term>Dopamine</term>
<term>Receptors, Dopamine D2</term>
<term>Receptors, Muscarinic</term>
<term>Receptors, Serotonin</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Dopamine D2 Receptor Antagonists</term>
<term>Muscarinic Antagonists</term>
<term>Receptor, Serotonin, 5-HT2A</term>
<term>Receptors, Dopamine D4</term>
<term>Serotonin Antagonists</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Radioligand Assay</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Corbett, R" sort="Corbett, R" uniqKey="Corbett R" first="R" last="Corbett">R. Corbett</name>
<name sortKey="Van Tol, H H" sort="Van Tol, H H" uniqKey="Van Tol H" first="H H" last="Van Tol">H H Van Tol</name>
</noCountry>
<country name="Canada"><region name="Ontario"><name sortKey="Seeman, P" sort="Seeman, P" uniqKey="Seeman P" first="P" last="Seeman">P. Seeman</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003861 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003861 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:9327943 |texte= Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:9327943" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |